Dendritic Cell Vaccine Inhibits Tumor Progression in Preclinical Liver Cancer Model
February 25, 2016 12:16 ET
|
Saronic Biotechnology, Inc.
NEW YORK, Feb. 25, 2016 (GLOBE NEWSWIRE) -- Saronic Biotechnology, Inc. today announces publication of preclinical data of autologous dendritic cell (DC) vaccine treatment in a murine model for...
Human Validation Data Supporting Saronic Biotechnology’s Lead Therapeutic SBI1997 Published in the Journal of Immunotherapy
February 09, 2016 11:10 ET
|
Saronic Biotechnology, Inc.
NEW YORK, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Saronic Biotechnology, Inc., a U.S. biotechnology company dedicated to developing novel immunotherapeutics for liver cancer, today announces the...
Saronic Biotechnology Files Investigational New Drug Application With FDA for SBI1997 Phase I/II Clinical Trial
December 18, 2015 10:20 ET
|
Saronic Biotechnology, Inc.
NEW YORK, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Saronic Biotechnology, Inc. announces the filing of an Investigational New Drug application with the United States Food and Drug Administration (FDA) for...